DBV Technologies S.A. - American Depositary Shares (DBVT)
DBVT moved a median of -0.15% 30 minutes after news, and -0.83% by the close. How DBVT actually reacts to news — the realized, point-in-time move the market made, measured across 327 labeled events over the last three years with zero look-ahead.
DBVT’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 36% | 292 |
| 30-min | -0.15% | 40% | 319 |
| 60-min | -0.21% | 43% | 323 |
| to close | -0.83% | 38% | 323 |
| Middle 50% of DBVT reactions | -1.50% to +0.73% |
|---|---|
| Median reaction (30-min) | -0.15% |
| Measured reactions | 327 |
Half of all DBV Technologies S.A. - American Depositary Shares news events land between -1.50% and +0.73% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How DBVT reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Coverage initiations | 65 | 0.00% | 37% | -1.00% |
| Rating reiterations | 43 | -0.21% | 35% | -1.04% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 4 further classes were observed with fewer than 10 measured events and are not published. See how DBVT ranks against every other measured name →
That’s how DBVT usually reacts — get an email when it moves on news →Email me when DBVT moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to DBVT's baseline. Nothing else.
Recent DBVT events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 8-K DBV Technologies S.A. For: Sep 29 | SEC filing · Form 8-K | SEC EDGAR | +1.11% | +0.34% | |
| DBV Technologies Announces Submission of Biologics License Application to U.S. FDA for the VIASKIN® Peanut Patch in Children Aged 4-7 Years | Press release | GlobeNewswire | +1.11% | +0.34% | |
| DBV Technologies to Participate in Upcoming September Investor Conferences | Press release | GlobeNewswire | +0.82% | +0.37% | |
| Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of August 31, 2026 | Press release | GlobeNewswire | -2.09% | -1.44% | |
| DBV Technologies Announces Sale of Approximately $50 Million of ADSs Through Its At-The-Market (ATM) Program on Nasdaq | Press release | GlobeNewswire | -1.68% | -1.53% | |
| DBV Technologies Files At-The-Market (ATM) Prospectus for Up to $150 Million of Sales | Press release | GlobeNewswire | -1.05% | +2.46% | |
| DBV Technologies Announces the Filing of its 2026 Half-Year Report ? Conditions for Accessing or Consulting the Report | Press release | GlobeNewswire | -1.83% | -2.33% | |
| DBV Technologies Reports Second Quarter and Half-Year 2026 Financial Results and Business Update | Press release | GlobeNewswire | -1.83% | -2.33% | |
| DBV Technologies Announces Inclusion in the Euronext Tech Leaders Index | Press release | GlobeNewswire | -0.71% | -3.35% | |
| DBV Technologies to Present New Positive Data from VITESSE Study and Preview Recently Initiated THRIVE Study at the EAACI Congress 2026 | Press release | GlobeNewswire | +0.19% | -0.68% | |
| Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 31, 2026 | Press release | GlobeNewswire | -1.61% | +1.15% | |
| DBV Technologies Announces First Participant Screened in THRIVE Phase 2 Study of the VIASKIN® Peanut Patch in Infants ages 6 through 12 Months with Peanut Allergy | Press release | GlobeNewswire | +0.61% | -1.01% | |
| Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of March 31, 2026 | Press release | GlobeNewswire | +0.63% | -1.97% | |
| DBV Technologies Reports Full Year 2025 Financial Results and Business Update | Press release | GlobeNewswire | +1.56% | -3.71% | |
| DBV Technologies to Participate in Upcoming March Investor Conferences | Press release | GlobeNewswire | -0.41% | -3.58% | |
| Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of February 28, 2026 | Press release | GlobeNewswire | -0.18% | +3.78% | |
| Form 8-K DBV Technologies S.A. For: Feb 28 | SEC filing · Form 8-K | SEC EDGAR | +1.79% | +9.82% | |
| DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting | Press release | GlobeNewswire | +1.79% | +9.82% | |
| DBV Technologies to Present Additional Data from the VITESSE Phase 3 Study of the VIASKIN® Peanut Patch in Children Ages 4-7 Years and Discuss Future of EPIT in the Treatment Landscape at AAAAI 2026 Annual Meeting | Press release | GlobeNewswire | -0.63% | +0.85% | |
| Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of January 31, 2026 | Press release | GlobeNewswire | -0.80% | +0.19% | |
| Form 8-K DBV Technologies S.A. For: Jan 16 | SEC filing · Form 8-K | SEC EDGAR | -0.27% | -0.71% | |
| Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF | Press release | GlobeNewswire | +0.00% | -5.24% | |
| Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025 | Press release | GlobeNewswire | +0.06% | -6.15% | |
| DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years | Press release | GlobeNewswire | +1.46% | -10.87% | |
| Form 8-K DBV Technologies S.A. For: Dec 16 | SEC filing · Form 8-K | SEC EDGAR | +1.46% | -10.87% | |
| DBV Technologies Announces Last Patient Visit Completed in VITESSE Phase 3 Clinical Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years | Press release | GlobeNewswire | +0.44% | -1.50% | |
| Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of October 31, 2025 | Press release | GlobeNewswire | +1.71% | +2.21% | |
| DBV Technologies to Participate in Upcoming ACAAI 2025 Annual Scientific Meeting | Press release | GlobeNewswire | -0.31% | -3.82% | |
| Form 8-K DBV Technologies S.A. For: Oct 30 | SEC filing · Form 8-K | SEC EDGAR | +2.41% | -4.56% | |
| DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq | Press release | GlobeNewswire | -0.31% | -3.82% | |
| Form 8-K DBV Technologies S.A. For: Oct 28 | SEC filing · Form 8-K | SEC EDGAR | -1.88% | +5.85% | |
| DBV Technologies Reports Third Quarter 2025 Financial Results | Press release | GlobeNewswire | -1.88% | +5.85% | |
| Form 10-Q DBV Technologies S.A. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | -1.88% | +5.85% | |
| DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq | Press release | GlobeNewswire | -1.53% | -5.00% | |
| DBV Technologies Announces Resignation of Board Member | Press release | GlobeNewswire | — | -0.63% | |
| Form 8-K DBV Technologies S.A. For: Sep 18 | SEC filing · Form 8-K | SEC EDGAR | — | -0.63% | |
| DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq | Press release | GlobeNewswire | +0.56% | -2.25% | |
| Form 8-K DBV Technologies S.A. For: Sep 05 | SEC filing · Form 8-K | SEC EDGAR | +0.56% | -2.25% | |
| Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2025 | Press release | GlobeNewswire | -0.11% | -5.78% | |
| DBV Technologies announces filing of 2025 Half-Year Report ? Conditions for accessing or consulting the Report | Press release | GlobeNewswire | +1.37% | -7.79% | |
| DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results | Press release | GlobeNewswire | +1.37% | -7.79% | |
| Form 10-Q DBV Technologies S.A. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +1.37% | -7.79% | |
| Form 8-K DBV Technologies S.A. For: Jul 29 | SEC filing · Form 8-K | SEC EDGAR | +1.37% | -7.79% | |
| Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF | Press release | GlobeNewswire | -4.25% | — | |
| DBV Technologies Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers 1 – 3 Years Old | Press release | GlobeNewswire | +0.00% | +2.11% | |
| Form 8-K DBV Technologies S.A. For: Jun 25 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +2.11% | |
| Form S-8 DBV Technologies S.A. | SEC filing · Form S-8 | SEC EDGAR | -1.97% | -1.48% | |
| DBV Technologies to Participate in Upcoming EAACI Congress 2025 | Press release | GlobeNewswire | -1.24% | -1.62% | |
| Form 8-K DBV Technologies S.A. For: Jun 11 | SEC filing · Form 8-K | SEC EDGAR | -0.24% | +3.31% | |
| Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 30, 2025 | Press release | GlobeNewswire | +0.00% | +2.40% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the DBVT section they belong to.
Where else DBVT is measured.
DBVT earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| BG MEDICINE INC (BGMD) | 329 | 0.00% | 39% |
| IQVIA Holdings, Inc. (IQV) | 329 | +0.02% | 51% |
| Novartis AG (NVS) | 326 | +0.03% | 51% |
| Theravance Biopharma, Inc. - Ordinary Shares (TBPH) | 326 | +0.10% | 57% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is DBV Technologies S.A. - American Depositary Shares's median reaction calculated?
Every labeled DBVT news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 327 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 40% of DBVT's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does DBVT's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.